Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
The Gross Law Firm issued a shareholder-solicitation notice naming Capricor Therapeutics; no new disclosure from the company itself. The firm alleges that Capricor made misleading statements regarding the statistical analysis plan for its lead candidate Deramiocel and failed to disclose that the FDA had not agreed to changes prior to BLA resubmission.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.